Prestige Consumer Healthcare
PBH · NYSE
$49.36−$0.35 (−0.70%)TodayMarket closed ·
Prev close $49.71
About PBH
- Employees
- 600
- Headquarters
- Tarrytown, New York
- Listed
- Feb 10, 2005
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Website
- prestigebrands.com
Leadership
| Name | Title | Since |
|---|---|---|
| Ronald Lombardi | — | 2010 |
| Christine Sacco | — | — |
| Adel Mekhail | — | — |
| William P'Pool | — | — |
| Jeffrey Zerillo | — | — |
| John Byom | — | — |
| Celeste Clark | — | — |
| James D'Arecca | — | — |
| Sheila Hopkins | — | — |
| John Kelly | — | — |
| Dawn Zier | — | — |
Revenue by product and region
Fiscal year ended Mar 31, 2026: $1.09B total revenue
By product
- Net sales$1.08B99.6%
- Other revenues$3.96M0.4%
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| Amazon.com AMZN | Supplier and customer | 0.07 |
| BioGaia B | Supplier | 0.00 |
| Walmart WMT | Customer | -0.10 |
| ECMOHO Sp ADS-A MOHO | Customer | -0.41 |
| SNCF Participations SA MLSNP.PA | Supplier | — |
Similar companies
Companies in the same industry as Prestige Consumer Healthcare
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.